undamentalytics Newsletter
Sign in

Fulgent Genetics, Inc. balance sheet

At the end of fiscal 2025, Fulgent Genetics, Inc. had total assets of $1.21bn, total liabilities of $107m and shareholders' equity of $1.11bn. It held $50.2m in cash against $2.4m of debt: net cash of $47.8m.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2014Dec 20142015Dec 20152016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Cash and equivalents—086712871658097555026
Receivables—244671841395351698565
Inventory————————————1
Total current assets—326334037524612628508354550455
Goodwill———————5114322222554
Total assets—6585754897001,2791,3861,2351,2201,2141,089
Accounts payable—0321226202315181916
Deferred revenue (current)————00271533243
Total current liabilities—133341301058873738572
Long-term debt————————33221
Total debt—0000001294322
Total liabilities—143361311131161029110793
Shareholders' equity25545451835691,1591,2671,1361,1331,1121,002
Net debt (negative = net cash)—−0−8−6−7−12−87−153−70−93−52−48−24
Shares outstanding———18m18m21m28m30m29m30m31m31m28m

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: CSTL vs FLGTFLGT vs SDGRFLGT vs MLABFLGT vs TWST

More: Life Sciences Tools & Services stocks compared, Health Care sector, rankings of US companies

Figures from Fulgent Genetics, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Fulgent Genetics, Inc.